#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3734216	F	Increase in insulin release in mouse BetaTC6 cells assessed as relative insulin release activity at 10 uM incubated for 2 to 4 hrs by FRET based HTRF assay relative to sunitinib	Mus musculus	355	ALA3727361	cell-based format	Patent Bioactivity Data
2.	ALA3734218	A	Cytotoxic activity against mouse C2C12 cells assessed as inhibition of cell proliferation of at 2 to 10 uM incubated for 72 hrs by MTT assay	Mus musculus	9	ALA3727361	cell-based format	Patent Bioactivity Data
3.	ALA3734223	B	Inhibition of GRK5 in mouse BetaTC6 cells assessed as increase in insulin release at 5 uM incubated for 2 hrs by ELISA	Mus musculus	7	ALA3727361	cell-based format	Patent Bioactivity Data
4.	ALA3734224	B	Inhibition of GRK5 in mouse BetaTC6 cells assessed as increase in insulin release at 2 to 10 uM incubated for 2 hrs in presence of high glucose media by ELISA	Mus musculus	4	ALA3727361	cell-based format	Patent Bioactivity Data
5.	ALA3734255	B	Inhibition of GRK5 in mouse C2C12 cells assessed as reduction in insulin secretion incubated for 2 hrs in presence of low glucose media by ELISA	Mus musculus	4	ALA3727361	cell-based format	Patent Bioactivity Data
6.	ALA3734267	B	Inhibition of N-terminal 6His-tagged recombinant full length human GRK5 incubated for 120 mins using casein substrate by ADP-Glo kinase assay	Homo sapiens	10	ALA3727361	single protein format	Patent Bioactivity Data
7.	ALA3734268	B	Inhibition of N-terminal 6His-tagged recombinant full length human GRK5 incubated for 40 mins using casein, substrate and [gamma-33P-ATP] by radiometric based filtration binding assay	Homo sapiens	4	ALA3727361	single protein format	Patent Bioactivity Data
8.	ALA3734269	B	Inhibition of GRK5 in mouse BetaTC6 cells assessed as ratio of insulin release at 2 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit)	Mus musculus	4	ALA3727361	cell-based format	Patent Bioactivity Data
9.	ALA3734270	B	Inhibition of GRK5 in mouse BetaTC6 cells assessed as ratio of insulin release at 5 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit)	Mus musculus	4	ALA3727361	cell-based format	Patent Bioactivity Data
10.	ALA3734271	B	Inhibition of GRK5 in mouse BetaTC6 cells assessed as ratio of insulin release at 10 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit)	Mus musculus	4	ALA3727361	cell-based format	Patent Bioactivity Data
11.	ALA3734274	B	Inhibition of GRK5 in mouse C2C12 cells assessed as increase in 2-NBDG uptake at 5 uM after 1 hr relative to DMSO	Mus musculus	5	ALA3727361	cell-based format	Patent Bioactivity Data
12.	ALA3734275	B	Inhibition of GRK5 in mouse BetaTC6 cells assessed as increase in 2-NBDG uptake at 5 uM after 1 hr relative to DMSO	Mus musculus	4	ALA3727361	cell-based format	Patent Bioactivity Data
13.	ALA3734276	B	Inhibition of GRK5 in mouse C2C12 cells assessed as reduction in insulin secretion ratio incubated for 2 hrs in presence of low glucose media by ELISA relative to DMSO	Mus musculus	2	ALA3727361	cell-based format	Patent Bioactivity Data